0001 1 COURT OF COMMON PLEAS 2 OF CUYAHOGA COUNTY, OHIO 3 - - - 4 CAESAR C. DAILEY, Individually, : 5 and as Administrator of the Estate : 6 of LILLIAN DAILEY, : 7 PLAINTIFF, : 8 -VS- : CASE NO. 9 OHIO PERMANENTE MEDICAL GROUP, : CV-07-629950 10 INC., ET AL., : 11 DEFENDANTS. : 12 - - - 13 Deposition of WILLIAM MALCOLM JAMIESON, 14 III, M.D. a witness herein, taken by the plaintiff 15 as upon direct examination pursuant to the Ohio 16 Rules of Civil Procedure and pursuant to Notice to 17 Take Deposition, duly issued and served, and 18 agreement and stipulations hereinafter set forth 19 at the offices of WILLIAM MALCOLM JAMIESON, III, 20 M.D., 2123 Auburn Avenue, Suite 104, Cincinnati 21 Ohio at 2:00 p.m. on Thursday, April 9, 2009, 22 before Pamela Sue Spangler, a notary public within 23 and for the State of Ohio, and also by means of 24 audiovisual equipment before Marlene Dory. SPANGLER REPORTING SERVICES, INC. 0002 1 - - - 2 APPEARANCES: 3 On behalf of the Plaintiff: 4 Howard D. Mishkind, Esq. 5 of 6 Becker & Mishkind Co., LPA 7 1660 West 2nd Street 8 Cleveland, Ohio 44113 9 On behalf of the Defendants: 10 Dirk E. Riemenschneider, Esq. 11 of 12 Buckingham, Doolittle & Burroughs 13 1375 East 9th Street 14 Cleveland, Ohio 44114 15 - - - 16 S T I P U L A T I O N S 17 It is stipulated by and between counsel for 18 the respective parties that the deposition of 19 WILLIAM MALCOLM JAMIESON, III, M.D., a witness 20 herein, may be taken as upon direct examination 21 pursuant to the Ohio Rules of Civil Procedure, and 22 pursuant to agreement; that the deposition may be 23 taken by audiovisual means by the videographer and 24 in stenotypy by the notary public-court reporter SPANGLER REPORTING SERVICES, INC. 0003 1 and transcribed by her out of the presence of the 2 witness; that the transcribed deposition is to be 3 submitted to the witness for his examination and 4 signature, and that signature may be affixed out 5 of the presence of the notary public-court 6 reporter. 7 - - - 8 I N D E X 9 WITNESS DIRECT EXAMINATION 10 WILLIAM MALCOLM JAMIESON, III, M.D. 4 11 - - - 12 E X H I B I T S 13 PLAINTIFF'S EXHIBITS MARKED 14 No. 1, "Uterine fibroids: Childbearing, 15 Cancer, and hormone effects. 86 16 No. 2, 2 pages of Dr. Jamieson, III's notes. 86 17 18 - - - 19 20 21 22 23 24 SPANGLER REPORTING SERVICES, INC. 0004 1 THE VIDEOGRAPHER: Today is April 2 the 9th, 2009. Time now is 2:09. This is in the 3 matter of Caesar C. Dailey, individually, and as 4 Administrator of the Estate of Lillian Dailey, 5 deceased, plaintiff, versus Ohio Permanente 6 Medical Group, Inc., et al. 7 It is in The Court of Common Pleas 8 of Cuyahoga County, Ohio. It is Case No. 9 CV-07-629950. 10 The court reporter is Pamela 11 Spangler, and I am Marlene Dori. We're with 12 Spangler Reporting Services in Cincinnati, Ohio. 13 Counsel, would you please introduce 14 yourselves? 15 MR. MISHKIND: Good afternoon. My 16 name is Howard Mishkind, and I am the attorney 17 that represents the family of Lillian Dailey. 18 MR. RIEMENSCHNEIDER: I'm Dirk 19 Riemenschneider. I represent Ohio Permanente 20 Medical Group. 21 THE VIDEOGRAPHER: Doctor, your 22 name is? 23 THE WITNESS: William M. Jamieson. 24 THE VIDEOGRAPHER: At this time -- SPANGLER REPORTING SERVICES, INC. 0005 1 This is the beginning of tape number one -- we'll 2 have the court reporter swear the witness, please. 3 (Witness sworn.) 4 THE VIDEOGRAPHER: You may begin at 5 this time. 6 MR. MISHKIND: Thank you very much. 7 WILLIAM MALCOLM JAMIESON, III 8 of lawful age, a witness herein, having been 9 previously sworn, was examined and testified as 10 follows: 11 DIRECT EXAMINATION 12 BY MR. MISHKIND: 13 Q. Would you please state your name for 14 the record? 15 A. William M. Jamieson. 16 Q. Dr. Jamieson, how are you this 17 afternoon? 18 A. Excellent, thank you. 19 Q. My name is Howard Mishkind. I'm 20 going to be questioning you this afternoon 21 relative to your background and the opinion that 22 you hold in the case of Lillian Dailey; is that 23 okay? 24 A. Yes. SPANGLER REPORTING SERVICES, INC. 0006 1 Q. Because we're doing this through the 2 electronic means where I'm not present with you, 3 and I'm doing it by phone, in the event that I cut 4 you off or the court reporter doesn't get my 5 entire question, if someone there would let me 6 know, I want to make sure that we have an accurate 7 transcript both with regard to my questions and 8 obviously I want to make sure that I hear your 9 answers completely. Is that fair? 10 A. Fair. 11 Q. If, again, for some reason you're 12 answering and I cut you off because I thought you 13 were done -- I'll try to hesitate as much as 14 possible to give that pause some security that we 15 know that you've finished, but if I do cut you 16 off, Doctor, just please tell me that you weren't 17 done, I will stop and let you finish your answer; 18 is that fair, sir? 19 A. Fair. 20 Q. Excellent, thank you very much. And 21 again, I appreciate you accommodating me today. I 22 was unable due to scheduling to make it down to 23 Cincinnati, but I certainly appreciate you 24 accommodating me relative to this discovery SPANGLER REPORTING SERVICES, INC. 0007 1 deposition today, doing it in the manner that we 2 are doing it. 3 Would you please tell me where your 4 practice is located, where your office is? 5 A. Cincinnati, Ohio. 6 Q. And your office address is what, 7 Doctor? 8 A. 2123 Auburn Avenue, Cincinnati, 9 Ohio. 10 Q. Who are you employed by, sir? 11 A. Self-employed. 12 Q. Do you have other physicians that 13 are in your practice group with you? 14 A. No. 15 Q. You understand that this is my 16 opportunity under Ohio Rules to ask you questions 17 for purposes of the -- this case that's scheduled 18 for trial this summer, and to obtain the opinions 19 and the bases for those opinions that you will be 20 providing at the time of the trial? 21 A. Yes. 22 Q. And I presume, because I know you've 23 had your deposition taken before, you recognize 24 that I will be relying upon the answers that you SPANGLER REPORTING SERVICES, INC. 0008 1 give today under oath? 2 A. Yes. 3 Q. If for any reason my question is not 4 clear, please just tell me -- Howard, I don't 5 understand what you're asking -- and I will 6 rephrase the question. 7 A. Very good. 8 Q. Doctor, I have issued a Notice to 9 Take Deposition which asks that you bring certain 10 items, and I want to, obviously, because I'm not 11 there, I want to determine whether or not you have 12 your complete file with you in terms of all 13 material that you have reviewed in connection with 14 this case. 15 A. Okay. 16 Q. Do you have everything with you? 17 A. I do. 18 Q. Has anything been removed from your 19 file prior to the start of this deposition? 20 A. No. 21 Q. In the request for discovery, the 22 Notice of Deposition, it also asks that you 23 provide a printout of all e-mails. Are there 24 e-mails that you have in front of you? SPANGLER REPORTING SERVICES, INC. 0009 1 A. No. 2 Q. Have you had any e-mail exchange 3 with Mr. Riemenschneider or anyone from his 4 office? 5 A. I'm not an e-mail kind of guy. 6 Q. I'll take it then the answer is no? 7 A. Never. 8 Q. Okay. I also asked for billing 9 records, do you have your billing records with you 10 today? 11 A. I don't. I'm sure Mr. 12 Riemenschneider has those. 13 Q. Can you tell me how many hours you 14 have put in on this case thus far? 15 A. I have no idea. 16 Q. Who manages your billing? 17 A. I do. 18 Q. And how do you keep track of the 19 time? 20 A. After I've read a deposition or read 21 the articles, I send a letter off to either Mr. 22 Riemenschneider or his secretary with my billable 23 hours. 24 Q. Sir, do you have with the material SPANGLER REPORTING SERVICES, INC. 0010 1 in front of you copies of all correspondence? 2 A. I believe so. 3 Q. And would the correspondence contain 4 copies of the billing that you submitted? 5 A. No, that's done on a month-to-month 6 basis, depending on how much time is put in. 7 Q. So when you send a bill to Mr. 8 Riemenschneider for the work on this case, you 9 would have enclosed a letter, enclosed please find 10 statement for services rendered, something to that 11 effect; is that true? 12 A. Correct. 13 Q. And where would a copy of that 14 letter and a copy of that bill for your record, 15 where would that be maintained? 16 A. In the trash can. 17 Q. So it's your testimony that without 18 checking perhaps deposits in your bank account, 19 the only way that we would be able to determine 20 how much you billed or how much you've been paid 21 is to provide that information from Mr. 22 Riemenschneider? 23 A. I'm sure he'd have much better 24 records of that than I do. SPANGLER REPORTING SERVICES, INC. 0011 1 Q. I'm sorry, sir? 2 A. I'm sure he'd have much better 3 records of that than I do. 4 Q. I'm not sure that I necessarily 5 agree or disagree with that, but my question is: 6 Short of asking him, how would we -- without going 7 to your bank records or looking at your tax 8 records, how would we know how much had been -- 9 has been paid to you relative to this case? 10 A. If you didn't go to him, I don't 11 think you'd ever have that information. 12 Q. Can you give me an estimate of the 13 amount of time that you have spent on this case? 14 A. Oh, 20, 30 hours. 15 Q. For purposes of today's deposition, 16 how much time did you spend preparing, rereviewing 17 the material, and spending with Mr. 18 Riemenschneider? 19 A. One hour today. 20 Q. Is the 20 to 30 hours, and I realize 21 that that's an estimate, but is that, in your 22 experience, is that basically within the type of 23 range that you spend on a case in terms of 24 reviewing, preparing a report, and preparing for SPANGLER REPORTING SERVICES, INC. 0012 1 deposition? 2 A. It all depends on how long the case 3 goes. But I would say that's probably average. 4 Q. One of the other items, sir, that I 5 asked for is medical literature which you reviewed 6 which supports your opinions. Do you have any 7 medical literature with you today? 8 A. I do have an article, yes. 9 Q. Which article would that be, sir? 10 A. That is -- it was an OB-GYN 11 Management, it was advising your patients on 12 Uterine fibroids: cancer and hormone effects by 13 William H Parker, M.D. 14 Q. When was that article published, 15 sir? 16 A. May of '08. 17 Q. Do you have any other literature 18 with you today, sir? 19 A. No, I don't. 20 Q. Is there any other literature that 21 you have reviewed at any time during the course of 22 this case? 23 A. No. 24 Q. Can you tell me why you selected SPANGLER REPORTING SERVICES, INC. 0013 1 that article as opposed to any other in the 2 medical literature? 3 A. When I first reviewed the case it 4 just happened to be one of those journals that had 5 that particular topic in it that I thought was 6 very relevant in this particular case. 7 Q. And what journal is that published 8 in, sir? I'm sorry. 9 A. It was OBG Management. 10 Q. What I'd like to do is, rather than 11 stopping at this particular point, if we can agree 12 that a copy of that article will be marked as 13 Plaintiff's Exhibit 1, we could substitute that in 14 at the time that we completed the deposition. 15 There may be some additional items, but do you 16 have any problem with photo copying? 17 A. No, that should not be a problem at 18 all. It's like four or five pages only. 19 Q. Great. Thank you very much, I 20 appreciate it. 21 A. You're welcome. 22 Q. So that would be the extent of the 23 literature that you have with you and the extent 24 of the literature that you've reviewed in SPANGLER REPORTING SERVICES, INC. 0014 1 connection with this case? 2 A. Yes. 3 Q. You obviously have your report, I 4 presume, which is dated August 27? 5 A. I believe I do, yes. 6 Q. Is that the only report that you've 7 written in this case, sir? 8 A. Yes. 9 Q. Did you prepare any drafts before 10 signing the report? 11 A. No. 12 Q. What about any notes that you would 13 have made when you were reviewing the records 14 prior to preparing the report? Are there any? 15 A. Not with me -- not that we have now. 16 Q. By your answer it sounds like at one 17 point there were notes? 18 A. Well, obviously when I review 19 records I usually put little notes to myself 20 before I write the -- I guess it would be the 21 report to Mr. Riemenschneider. 22 Q. And what happened to those notes 23 after you wrote the report? 24 A. I usually throw them away. I've got SPANGLER REPORTING SERVICES, INC. 0015 1 some notes, but not all notes. As I review 2 records I'll take little notes to myself. I've 3 got some, but probably not all. 4 Q. Would these notes that you have, 5 sir, would they be since you prepared the report 6 or is it difficult to tell when those notes were 7 made? 8 A. No. Most of them would have been 9 before I prepared the report, yes. 10 Q. Do you have any notes that you have 11 prepared since the August 27th report? 12 A. No. 13 Q. Again, because of my disadvantage of 14 not being there, are the notes -- how many pages 15 of notes do you have, sir? 16 A. There's one -- two. 17 Q. How legible is your handwriting? 18 A. Pretty doggone legible. 19 Q. Great. What we'll do, Doctor, is if 20 this is okay with you and okay with Mr. 21 Riemenschneider, we will mark your notes, two 22 pages, as Plaintiff's Exhibit 2 and attach that to 23 the transcript? 24 A. Okay. SPANGLER REPORTING SERVICES, INC. 0016 1 Q. Is that reasonable? 2 A. Yes. 3 MR. RIEMENSCHNEIDER: No problem 4 with that. 5 Q. Other than the two pages of notes 6 and those notes that you would have had prior to 7 preparing your report that you no longer have 8 after signing this report, would there be any 9 other notations anywhere in any of the material 10 that you've reviewed, either marginal notes, notes 11 on any reports, anything else that would have your 12 handwriting on it other than what we've just 13 marked as Plaintiff's Exhibit 2? 14 A. No. 15 Q. Doctor, I have your report which 16 identifies material which you had reviewed as of 17 August 27, 2008, it's the second paragraph of your 18 report. 19 A. Yes. 20 Q. Was there any other material, sir, 21 that you had reviewed prior to preparing this 22 August 27th report? 23 A. No. 24 Q. Since preparing the August 27th SPANGLER REPORTING SERVICES, INC. 0017 1 report, have you received any additional material? 2 A. No. Well, depositions, yes. 3 Q. Tell me, if you would, what material 4 you have received since the August 27th, 2008 5 report? 6 A. Timing I'm not exactly sure, but I 7 would guess it would be the depositions of the 8 physicians at Kaiser, the deposition of your 9 expert witness, and then I just received last 10 night the deposition of Dr. Young. 11 Q. And did you read Dr. Young's report? 12 A. I did. 13 Q. I'm sorry, his deposition. Excuse 14 me. 15 A. Yes, I did. 16 Q. Had you seen anything authored by 17 Dr. Young prior to receiving the deposition last 18 night? 19 A. No. 20 Q. Have you been provided with any 21 other expert reports from the definition in 22 connection with this case? 23 A. I don't believe so. 24 Q. You've read Dr. McLellan's SPANGLER REPORTING SERVICES, INC. 0018 1 deposition? 2 A. I did. 3 Q. Did you also read his report? 4 A. I did. 5 Q. You mentioned depositions that you 6 received after you had prepared your August 27th, 7 2008 report, and correct me if I'm wrong, but I 8 believe what you told me was you had received 9 depositions of doctors from Kaiser, you received 10 Dr. McLellan's, who you referred to as my expert's 11 depositions, and then last night receiving Dr. 12 Young's deposition? 13 A. Correct. 14 Q. And you carefully reviewed Dr. 15 McLellan's deposition? 16 A. I did. 17 Q. When would you have last read his 18 deposition? 19 A. Oh, my goodness, whenever it was 20 sent to me, and I couldn't -- well, maybe -- I 21 wouldn't have that. Probably within the last -- 22 whenever the deposition was, and whenever it was 23 sent out, probably a week or so after that. 24 Q. Do you know the names of any of the SPANGLER REPORTING SERVICES, INC. 0019 1 other experts for the defense in this case? 2 A. No, I don't. 3 Q. So you've not been made aware of Dr. 4 Barter, a GYN oncologist involved in this case? 5 A. I think Dirk just mentioned his name 6 for the first time to me today, yes. 7 Q. And that's the first time that you 8 would have been aware of his name after reviewing 9 all of the material, including Dr. McLellan's 10 deposition? 11 A. Yes. 12 Q. Did you make any notes when you read 13 Dr. McLellan's deposition? 14 A. I did. 15 Q. And are those on those two pages, or 16 are they someplace else? 17 A. That's one of the two pages. 18 Q. So the two pages, if we were to 19 spend time talking about them, they have to do 20 with Dr. McLellan's opinion? 21 A. Dr. McLellan's opinions, and then my 22 summary of the case, of the original records. 23 Q. Okay. Have you reviewed the actual 24 ultrasounds that were taken in this case? SPANGLER REPORTING SERVICES, INC. 0020 1 A. Just the reports. 2 Q. Have you reviewed the results of the 3 endometrial biopsy? 4 A. Yes. 5 Q. Did you -- you read the report or 6 did you actually see any slides? 7 A. No, I just read the report. 8 Q. Okay. Other than what's in your 9 report and what we've talked about, as far as this 10 article, Dr. McLellan's report, his deposition, 11 Dr. Young's deposition received last night, and 12 the depositions that you received from the Kaiser 13 doctors after your reports, is there anything else 14 other than cover letters that would have been 15 exchanged, enclosed please find, is there anything 16 else that you have in front of you that we haven't 17 at least itemized? 18 A. I think -- I guess it goes without 19 saying I've got her records from -- I guess it 20 would be the hospital or the clinic. 21 Q. Okay. Now, in your report you had 22 referenced all records from Ohio Permanente 23 Medical Group pertaining to Lillian Dailey. In 24 your report you don't reference anything about the SPANGLER REPORTING SERVICES, INC. 0021 1 Cleveland Clinic records. Did you not have them 2 when you wrote your report? 3 A. I probably lumped it all together. 4 Q. In fairness to you, then, is it 5 reasonable to say that, even though you didn't 6 reference the Cleveland Clinic records, you most 7 likely had them when you wrote your report? 8 A. Yes, because I think they all came 9 in one large folder. 10 Q. Okay. Anything else that you had at 11 the time of your report or anything that you've 12 received since the report that we haven't 13 outlined? 14 A. Not to my knowledge. 15 Q. Great, thank you. 16 Do you know any of the experts in 17 this case? You mentioned that you heard for the 18 very first time talking with Dirk the name of Dr. 19 Barter; do you know who he is? 20 A. I don't. 21 Q. Do you know Dr. McLellan? 22 A. No, I don't. 23 Q. Do you know anything about him by 24 way of reputation? SPANGLER REPORTING SERVICES, INC. 0022 1 A. No. 2 Q. Do you know Dr. Young? 3 A. No. 4 Q. Do you know anything about him by 5 way of reputation? 6 A. No. 7 Q. Doctor, the report of August 27, 8 2008, does this contain a summary of the opinions 9 that you hold in this case? 10 A. Yes. 11 Q. And do you -- you hold to those 12 opinions that you expressed back in August of 13 2008? 14 A. Yes. 15 Q. Have your opinions changed in any 16 respect since writing the report and reviewing the 17 additional material that you received, sir? 18 A. No. 19 Q. Your opinion -- at least one of the 20 opinions, and we're going to go through all of 21 them, but I'm just centering in on one right now, 22 and that is -- and I'll even try to reference 23 where it is, I think it's on page 2, the third 24 complete paragraph. SPANGLER REPORTING SERVICES, INC. 0023 1 A. Yes. 2 Q. Where you state, and I'm taking a 3 portion of that sentence. Where you state "At no 4 time was there a breach in the standard of care 5 rendered to this patient." 6 Is it still your opinion that 7 throughout the entire course of treatment that's 8 in question from November of '04 up until the time 9 that the diagnosis was made, is it still your 10 opinion that all of the care complied with the 11 standard of care by the caregivers at Kaiser? 12 A. Yes. 13 Q. No question in terms of any aspect 14 of the care being below what you would consider to 15 be accepted standard? 16 A. There's no change, in my opinion. 17 Q. And as you look at the case from 18 November of 2004 -- 19 By the way, who was it that saw this 20 patient in November of 2004? 21 A. I believe it was a nurse 22 practitioner. 23 Q. Do you recall her name? 24 A. No, I don't. SPANGLER REPORTING SERVICES, INC. 0024 1 Q. Do you have -- I know that you 2 referenced a number of depositions in your report 3 of August 27th. Can you tell me the names of the 4 individuals that you received depositions from -- 5 from Kaiser after August -- after your August 27th 6 report? 7 A. I guess it would be the same ones I 8 have here, Verghese, Grayson, Shuffer, Gibbs and 9 Green. 10 Q. And you don't have any other 11 depositions? 12 A. Well, we talked about Dr. 13 McLellan's. 14 Q. Sure, I'm sorry, sir, other than Dr. 15 McLellan and Dr. Young? 16 A. Well, let's see here, these are the 17 records. This is a deposition of Phillip Shuffer, 18 M.D. this is a deposition of Evelyn James, R.N. 19 Q. And who is Evelyn James, R.N.? 20 A. I assume she's a nurse, certified 21 nurse practitioner. 22 Q. Do you know what aspect of the care 23 she was involved in? 24 A. I'm assuming that she was the one SPANGLER REPORTING SERVICES, INC. 0025 1 that did the original Well Woman Exam. 2 Q. When you say "assuming"; do you know 3 that based upon your review to be a fact? 4 A. I know that there was a nurse 5 practitioner, I'm not -- the name I'm not sure 6 makes relevance, but I know it was a nurse 7 practitioner that saw her in November. 8 Q. But as you sit here right now -- I'm 9 not trying to play games with words -- but as you 10 sit here right now, this Evelyn James, the nurse 11 practitioner, you're just not certain whether this 12 is the one that saw her in November? 13 A. I'm not. 14 Q. Okay. Please continue, sir. 15 A. Let's see, Melanie Gibbs, and that 16 pretty much does it. 17 Q. Do you know, based upon your review 18 or recollection? 19 A. Excuse me, Albert Green, also. 20 Q. Okay. And I think that if we look 21 at your report of August 27, the only deposition 22 from Kaiser that was not identified in your report 23 is that of Evelyn James, I think the others in the 24 second complete paragraph on the first page you SPANGLER REPORTING SERVICES, INC. 0026 1 indicated you -- 2 A. Correct. 3 Q. -- you had at the time you prepared 4 the report? 5 A. Correct. 6 Q. And again, just -- I don't mean to 7 beat a dead horse with a stick, but the Evelyn 8 James from Kaiser would be the only additional 9 deposition that you received after report other 10 than Dr. McLellan's deposition and Dr. Young's 11 deposition? 12 A. Correct. 13 Q. Great. Thank you, sir. 14 MR. MISHKIND: So far are we doing 15 okay in terms of transmission? 16 THE COURT REPORTER: You're doing 17 great, thank you. 18 MR. MISHKIND: Thank you very much, 19 ma'am. 20 BY MR. MISHKIND: 21 Q. So the care that Evelyn -- I'm 22 sorry. 23 The care that Lillian received at 24 Kaiser from November up until the time of the SPANGLER REPORTING SERVICES, INC. 0027 1 diagnosis, is this the same type of care that you 2 would expect would be received if Lillian had been 3 a patient of yours? 4 MR. RIEMENSCHNEIDER: Objection. 5 Go ahead. 6 A. Yes. 7 Q. No aspect of the care in terms of 8 testing, examination, or follow-up would have been 9 any different than what happened to Kaiser? 10 A. Well, my understanding is is that 11 she was supposed to make an appointment with a 12 gynecologist which she failed to do. 13 Q. Okay. And tell me where you get 14 that evidence. 15 A. I'm sure it's someplace either in 16 the deposition or the records. 17 Q. Well, Doctor, understand today is my 18 opportunity to find out where -- what evidence 19 you're relying upon to make a statement that she 20 failed to schedule an appointment that she was 21 supposed to, and that's why I'm asking you, as you 22 sit here giving your deposition, on what are you 23 basing that statement that she failed to make an 24 appointment that she was supposed to make? SPANGLER REPORTING SERVICES, INC. 0028 1 A. Because she never came in. 2 Q. Well, but where is -- where is there 3 an indication that she was told to make an 4 appointment? 5 A. I'm sure it's someplace in the 6 deposition or the records. 7 Q. Oh. Can you tell me whether -- 8 let's just concentrate on the record. Is there 9 anything in the record that you reviewed that 10 would indicate that she was scheduled to make an 11 appointment and she didn't? 12 A. My understanding is the nurse 13 practitioner told her to make an appointment with 14 the gynecologist, the patient never made that 15 appointment or showed up. And that's just 16 evidence of the records, because we don't have any 17 records of Lillian until she comes in in May. 18 Q. Doctor, tell me what your 19 understanding is of the system at Kaiser in terms 20 of scheduling appointments and scheduling tests 21 such as ultrasounds? 22 A. I'm assuming that the nurse 23 practitioner probably ordered the ultrasound and 24 I'm assuming she told the patient to make an SPANGLER REPORTING SERVICES, INC. 0029 1 appointment with a gynecologist, and that's all I 2 know. 3 Q. When you say -- very obscure when 4 you say you're assuming. 5 A. Because that's what's in the 6 records. 7 Q. Fair enough. I just want to make 8 sure that when you say you're assuming that you're 9 not speculating, this is based upon your review? 10 A. Correct. 11 Q. Now, in terms of follow-up, if 12 there's a note in the record that a patient is 13 supposed to schedule an appointment, do you know 14 what system Kaiser had to follow up to make sure 15 that that appointment was scheduled or kept? 16 A. I have no idea what their system is. 17 Q. Do you know how many times Evelyn -- 18 I'm sorry, Lillian was seen after November by 19 other practitioners at Kaiser before she was seen 20 in May? 21 A. I don't recall. 22 Q. And would you expect that, if 23 someone had the chart when she was seen between 24 November and May, and the notation about a SPANGLER REPORTING SERVICES, INC. 0030 1 follow-up appointment had been in front of that 2 particular physician, that there would have been 3 some discussion as to whether the patient 4 scheduled an appointment or why the patient didn't 5 schedule an appointment? 6 MR. RIEMENSCHNEIDER: Objection. 7 Go ahead. 8 A. Well, I would -- I don't know if 9 that -- there was a statement made to that effect. 10 I think if I saw it on there I think I would say 11 did you make your appointment with the 12 gynecologist? 13 Q. And that would be a reasonable and 14 prudent thing to do, correct? 15 MR. RIEMENSCHNEIDER: Objection. 16 A. Well, it depends on who I'm seeing. 17 And if I'm there for upper respiratory, then I 18 don't think those doctors are too concerned about 19 her ultrasound. 20 Q. Okay. What about the -- well, let 21 me ask you this: 22 Do you believe, assuming that the 23 patient was told to schedule an appointment, and 24 assuming that she didn't schedule an appointment, SPANGLER REPORTING SERVICES, INC. 0031 1 do you believe that the patient -- that that would 2 have altered the outcome in this case? 3 A. No. 4 Q. Okay. Do you know what kind of -- 5 because you -- Well, strike that. 6 Because you've read the various 7 depositions, you know when the patient was seen by 8 Dr. Grayson -- First of all, what type of 9 physician Dr. Grayson is. 10 A. Offhand I have no idea. 11 Q. Do you know when she was seen by Dr. 12 Grayson? 13 A. Offhand I have no idea. 14 Q. Do you know when you look at the 15 ultrasound -- 16 Do you have copies of the 17 ultrasounds? 18 A. I have the reports, that's all. 19 Q. If you would take a look at the 20 first ultrasound from November of '04? 21 A. Yes. 22 Q. If you could look at who the 23 ordering physician is? 24 A. I just have notes on that, I don't SPANGLER REPORTING SERVICES, INC. 0032 1 have the ordering physician. 2 Q. I'm sorry? 3 A. I just have notes of it, I don't 4 have the actual copy in front of me, but I'll take 5 your word for it. 6 Q. If it says it was ordered by 7 Patricia Grayson, what responsibility is there for 8 an ordering physician that receives an ultrasound 9 on a patient that is designated as being abnormal? 10 What duty or responsibility is there in terms of a 11 follow-up? 12 A. Well, abnormal, the fact that 13 they're fibroids, I'm not going to get too excited 14 about that as far as that ultrasound report. I'm 15 not feeling like I'm missing anything. And 16 apparently she looked at the records and she was 17 told to make an appointment. 18 Q. But you go back to that, other than 19 the notes in the record, do you see any evidence 20 that an appointment was scheduled by the 21 scheduling department for Lillian and she failed 22 to keep the appointment? 23 A. I have no idea. 24 Q. Well, as you sit here now, do you SPANGLER REPORTING SERVICES, INC. 0033 1 know of any evidence that there was an appointment 2 scheduled? 3 A. I have no idea. I was under the 4 impression that the patient was supposed to make 5 an appointment. 6 Q. As far as the ultrasound, do you 7 know how the ultrasound got scheduled, the 8 November ultrasound that we're referring to? 9 A. I'm assuming that Nurse Evans or 10 Grayson or whatever her name was -- 11 Q. I guess what I'm trying to 12 understand is: How did the ultrasound get 13 scheduled and this follow-up visit not get 14 scheduled? 15 A. I have no idea. I'm assuming the 16 patient wasn't having any problems and didn't 17 think it was necessary once she found out it was 18 just fibroids. 19 Q. Well, Doctor, let me ask you: 20 What evidence at all do you know of 21 or that you've seen, based upon your careful 22 review in this case, that the patient was notified 23 by anyone at Kaiser of the results of the 24 ultrasound? SPANGLER REPORTING SERVICES, INC. 0034 1 A. I don't think it's their 2 responsibility. If I have a normal ultrasound, if 3 I have fibroids, which is a benign condition, I 4 would not necessarily call the patient and give 5 her those results. 6 Q. Doctor, the reason I ask that is 7 because a moment ago you said, I assume that she 8 was told that it was -- that it was normal or that 9 it was fibroids and because she wasn't having any 10 problems she didn't schedule any appointments. My 11 question to you is: 12 Do you see any evidence that the 13 results, normal or abnormal were ever communicated 14 to Lillian before she came back in May? 15 A. I have no recollection. 16 Q. Would you agree that a patient has 17 the right to know the results of tests that are 18 performed on them? 19 A. If they're significant, yes. 20 Q. And if a result is abnormal and may 21 be reflective of a serious condition, can we agree 22 that the physician or the health care provider has 23 a duty to notify the patient? 24 MR. RIEMENSCHNEIDER: Objection. SPANGLER REPORTING SERVICES, INC. 0035 1 Go ahead. 2 A. Yes, if it's a serious condition. 3 Q. All right. Doctor, I want to shift 4 away from the case for a few minutes and ask you 5 some questions about your experience as an expert 6 witness and then we'll get back into the specifics 7 of Lillian's case. 8 A. Okay. 9 Q. Is that okay? 10 A. Sure. 11 Q. Thank you. 12 Have you ever testified in Federal 13 Court? 14 A. Federal Court, no. 15 Q. You have not then been required to 16 prepare what's known as a Rule 26 Disclosure 17 Statement? 18 A. I have not. 19 Q. Have you ever prepared a list of the 20 names of the cases and lawyers that you've worked 21 with over the past 20 or so years? 22 A. Never had to do that. 23 Q. Okay. You are not Board Certified 24 in GYN Oncology, are you? SPANGLER REPORTING SERVICES, INC. 0036 1 A. Correct. 2 Q. And if I -- looking at your CV, I 3 don't believe that you have any special training 4 or certification in the area of GYN oncology, do 5 you? 6 A. Correct. 7 Q. No residency or fellowship? 8 A. Correct. 9 Q. And you wouldn't hold yourself out 10 as an expert in the area of gynecological 11 oncology, would you? 12 A. Correct. 13 Q. Would you agree that the earlier 14 Lillian's cancer had been diagnosed, assuming 15 hypothetically it should have been diagnosed 16 sooner, would you agree that the earlier it was 17 diagnosed, the greater the chances of survival 18 would have been? 19 A. That's a very, very broad question, 20 but as a general rule, any cancer that is 21 diagnosed earlier will probably have a better 22 prognosis. 23 Q. Now, as far as this being 24 leiomyosarcoma or a high grade endometrial SPANGLER REPORTING SERVICES, INC. 0037 1 sarcoma, do you know whether the prognosis for a 2 stage 1 leiomyosarcoma compared to a high grade 3 endometrial sarcoma is any different? 4 A. I think the prognosis is 5 obviously -- usually related to the stage of the 6 disease, so the higher the stage, the worse 7 prognosis. 8 Q. That wasn't really my question. 9 There are different types of uterine sarcomas, 10 correct? 11 A. Yes. 12 Q. And in terms of the type of uterine 13 sarcoma, whether it be a carcinosarcoma or 14 leiomyosarcoma or a high grade endometrial 15 sarcoma, any of those uterine sarcomas, if a 16 patient is fortunate enough to have it diagnosed 17 at stage 1, do you know whether there's any 18 difference in terms of the prognosis for cure in 19 the five-year survival for any form of uterine 20 sarcoma diagnosed at stage 1? 21 A. I believe the endometrial carcinoma 22 sarcoma that she had, the aggressive type, 23 wouldn't have made any difference at what stage, 24 she would have eventually died of the disease. SPANGLER REPORTING SERVICES, INC. 0038 1 Q. And, Doctor, are you basing that on 2 what Dr. Young had to say? 3 A. Sounds like a pretty aggressive 4 tumor. 5 Q. You didn't -- my question was: Were 6 you basing that on what you've seen from Dr. 7 Young's deposition? 8 A. Yes. 9 Q. Okay. You're not an expert in the 10 area of GYN pathology or GYN oncology, are you? 11 A. We've established that. 12 Q. Okay. So as far as a stage 1 13 disease on uterine sarcomas, can we agree that by 14 definition a stage 1 uterine sarcoma is where the 15 disease is confined to the uterine corpus? 16 MR. RIEMENSCHNEIDER: Objection. 17 Go ahead. 18 A. I believe so. 19 Q. And in terms of stage 2, where has 20 the disease evolved or where has it spread outside 21 of the corpus to be a stage 2? 22 A. The other pelvic organs. 23 Q. That's your definition of stage 2? 24 A. Yes. SPANGLER REPORTING SERVICES, INC. 0039 1 Q. Okay. Then what's your definition 2 of stage 3? 3 A. Outside the pelvis. 4 Q. And what's your definition of stage 5 4? 6 A. Distant metastasis. 7 Q. And, Doctor, you believe that the 8 stages you just gave to me would be supported by 9 the medical literature? 10 A. To the best of my knowledge. 11 Q. Okay. It looks, in reviewing your 12 reports, that the opinions that you intend to 13 provide at the time of the trial of this matter 14 are confined to standard of care, am I correct? 15 A. Yes. 16 Q. So even though you said it looks 17 like it was a fairly aggressive cancer and it 18 wouldn't have made a difference, as an expert in 19 this case, do you intend to provide testimony on 20 causation? 21 A. I defer to the pathologist. 22 Q. Okay. And certainly GYN oncologists 23 would also be qualified to provide such opinion on 24 the staging as well as the likelihood of survival; SPANGLER REPORTING SERVICES, INC. 0040 1 can we agree upon that? 2 A. Yes. 3 Q. And you would defer to those people, 4 because that's not your area of expertise? 5 A. Yes. 6 Q. Okay. Doctor, have you had your 7 deposition taken more recently than September of 8 2008? 9 A. Hmm, I believe there was a 10 deposition in January of this year. 11 Q. You have been doing this type of 12 work over this 25, 26 years now? 13 A. Probably, yes. 14 Q. In terms of the percentage of the 15 cases where you're retained, can you tell me what 16 your testimony is as to the percentage defense 17 versus percentage plaintiff. 18 A. Seventy-five percent defense, 19 twenty-five percent plaintiff. 20 Q. Has there been a time where the 21 percentage that you were doing defense was at or 22 around 90 percent? 23 A. I don't believe so. 24 Q. In the early 2000s, you don't SPANGLER REPORTING SERVICES, INC. 0041 1 believe the percentage was closer to 90 percent? 2 A. I couldn't tell you. 3 Q. For purposes of trial, if you are at 4 trial for a full day, is the charge still $9,000? 5 A. Yes. 6 Q. Plus expenses? 7 A. Yes. 8 Q. How many times, sir, have you 9 actually testified in a courtroom? 10 A. Probably five. 11 Q. On how many occasions have you been 12 qualified by a court to give expert testimony? 13 A. I don't understand the question. 14 Q. You don't recall ever being asked 15 that question before? 16 A. I'm not sure what you mean by 17 "qualified." 18 Q. You wouldn't give an answer to a 19 question unless you understood the question, 20 right? 21 A. I -- hopefully not. 22 Q. Okay. So when I ask you how many 23 occasions you've been qualified by a court to give 24 expert testimony, you don't understand what that SPANGLER REPORTING SERVICES, INC. 0042 1 means? 2 A. I have no idea. I've never been 3 disqualified, if that's a better answer. 4 Q. Your testimony is testifying in a 5 courtroom in a medical malpractice case you 6 testified five times? 7 A. Probably, yes. 8 Q. On how many occasions have you had 9 your deposition taken over the course of your 10 career serving as a legal expert? 11 A. Twenty-five. 12 Q. As a medical expert, I should say. 13 A. Twenty-five, thirty-five times at 14 least. 15 Q. And on how many occasions have you 16 been retained as an expert to review a case during 17 the course of your career? 18 A. Probably at least twice that amount. 19 Q. In the year 2008 that we just 20 recently completed, how many times were you 21 deposed? 22 A. Probably twice. 23 Q. Are you able to tell me in 2007 24 whether you were deposed more than twice? SPANGLER REPORTING SERVICES, INC. 0043 1 A. I have no idea. 2 Q. In 2008, is this now your second 3 deposition? 4 MR. RIEMENSCHNEIDER: 2009? 5 Q. I'm sorry. 2009. Time flies when 6 you're having fun. 7 A. I believe two, yes. 8 Q. This is the second one, sir? 9 A. I believe so. 10 Q. And on average what is your 11 testimony as to how many cases you review on a 12 yearly basis? 13 A. I probably review probably 20 of 14 which -- half of which I won't take. 15 Q. Of the 20, you wind up accepting 16 roughly ten cases to participate as an expert? 17 A. Yeah. That's probably a little on 18 the high side, but let's say eight to ten. 19 Q. And, Doctor, have you ever been 20 involved in a case that you accepted that to your 21 knowledge the case was lost? 22 A. No. 23 Q. Do you or have you ever advertised? 24 A. Yes. SPANGLER REPORTING SERVICES, INC. 0044 1 Q. Do you continue to advertise? 2 A. Yes. 3 Q. Okay. Let's talk about that. Do 4 you still advertise with JurisPro? 5 A. Yes. 6 Q. Do you still advertise with 7 expertwitnesses.com? 8 A. I'm not sure. SEAK is the only 9 other one I'm aware of, S E A K. 10 Q. You're not familiar with advertising 11 with expertwitnesses.com? 12 A. You know, I get solicitation from 13 those, you know, a lot of the places. I couldn't 14 tell you. My understandings is that there's just 15 two. 16 Q. And your understanding is it's 17 JurisPro and SEAK, S E A K? 18 A. Correct. 19 Q. You have a website, correct? 20 A. Yes. 21 Q. Tell me about your consultation that 22 you do for Gynecare. 23 A. Gynecare. 24 Q. I'm sorry, G Y N E C A R E. SPANGLER REPORTING SERVICES, INC. 0045 1 A. Gynecare is a branch of Ethicon 2 Endo-Surgery. They have a device that I have been 3 a consultant for called the Thermachoice Balloon. 4 Q. How long have you been a consultant 5 for them, sir? 6 A. Ten years. 7 Q. How about NovaCare? Tell me about 8 your position as a consultant for them. 9 A. Another device company, been sold, 10 they're now with Hologic, and I've been with them 11 since the inception of the company, so that would 12 be probably seven years. 13 Q. Tell me about your work for 14 Prudential Insurance Company. 15 A. As an advisor. 16 Q. What does that mean? 17 A. Review records. 18 Q. Does it have to do with medical 19 malpractice issues? 20 A. No, no, no. 21 Q. Just utilization and reasonableness 22 of care? 23 A. Correct. 24 Q. What about your work for Community SPANGLER REPORTING SERVICES, INC. 0046 1 Mutual of Southwest Ohio? 2 A. Exact same thing. 3 Q. Tell me about your work as an expert 4 witness for the OB-GYN State Medical Board? 5 A. Actually it's the State Medical 6 Board of Ohio. I'm given records to -- that may 7 or may not have anything to do with OB-GYN. 8 Sometimes they're ethical issues, sometimes 9 they're prescribing issues, it's just a matter of 10 reviewing the records to see if there had been any 11 legal problems. 12 Q. Do you still do that work? 13 A. Probably once every two years. 14 Q. You speak -- I'm looking at your CV. 15 It says "Speaks nationally on topics related to 16 gynecological surgery"? 17 A. Yes. 18 Q. Do you speak nationally on topics 19 related to gynecological oncology? 20 A. No. 21 Q. Your area of interest, is it more in 22 the laparoscopic surgical arena? 23 A. Laparoscopic and hysteroscopic, yes. 24 Q. What percentage would you say your SPANGLER REPORTING SERVICES, INC. 0047 1 practice is laparoscopic versus -- as well as 2 hysteroscopic? 3 A. Surgery probably makes up 25, 30 4 percent of my practice. 5 Q. Do you or have you in your practice 6 diagnosed a patient with uterine sarcoma? 7 A. Only after the hysterectomy. 8 Q. Have you referred patients that you 9 suspected had uterine sarcoma or uterine cancer to 10 other physicians? 11 A. If I have a diagnosis of uterine 12 cancer I would send them to an oncologist, yes. 13 Q. In terms of the surgical and medical 14 management of a patient with uterine cancer, 15 including but not limited to uterine sarcoma, that 16 would be something that you would refer to a 17 specialist, a GYN oncologist? 18 A. If we're talking about endometrial 19 cancer, if we're talking about an early stage in a 20 well differentiated carcinoma, I would probably do 21 that myself. But all other advance cancers, I 22 would certainly refer. 23 Q. Do you know offhand what the 24 five-year survival rate is in an early stage SPANGLER REPORTING SERVICES, INC. 0048 1 uterine sarcoma of the type that Lillian had? 2 A. I believe I've seen 50 percent in 3 stage 1. 4 Q. Okay. Sir, I ask this of all 5 experts, so I don't mean any disrespect by this, 6 but have you ever been a party to any medical 7 negligence case as a defendant? 8 MR. RIEMENSCHNEIDER: Objection. 9 Go ahead. 10 A. No. 11 Q. With the same qualifier that I just 12 made a moment ago, have you ever had your 13 privileges suspended or revoked? 14 A. No. 15 Q. Have you ever been the subject of 16 any disciplinary action before any state medical 17 board? 18 A. No. 19 Q. Have you ever applied for privileges 20 to a hospital and been denied? 21 A. No. 22 Q. In terms of the cases that you are 23 involved in, can you tell me when it was that you 24 last testified either in deposition or at trial SPANGLER REPORTING SERVICES, INC. 0049 1 for a plaintiff's attorney? 2 A. Probably last summer. 3 Q. Would that be summer of '08 or 4 summer of '07? 5 A. Probably '0 -- I'm going to say '07. 6 Q. Where was that case, sir? 7 A. Dayton, Ohio. 8 Q. Who was the plaintiff's attorney? 9 A. Greg Gibson. 10 Q. You've worked with Greg on a number 11 of cases, haven't you? 12 A. He used to be with a defense team in 13 Dayton. I've done probably -- probably reviewed, 14 oh, at least a half a dozen cases of which maybe 15 two or three I thought had merit. 16 Q. Back in the early 2000s you remember 17 testifying for Mr. Gibson in the case of Michael 18 Johnson versus Donald Johnson, M.D.? 19 A. Probably, but you could review my -- 20 or refresh my memory. 21 Q. The only reason I say it is because 22 it was somewhat unusual in that it was Johnson 23 versus Johnson. And Donald B. Johnson was the 24 defendant in Clark County. None of that SPANGLER REPORTING SERVICES, INC. 0050 1 necessarily causes a light to go off? 2 A. No. 3 Q. Okay. Fair enough. 4 Besides Mr. Gibson, can you give me 5 the names of any other plaintiff attorneys in the 6 last five years that you have been retained by and 7 either given deposition testimony or trial 8 testimony? 9 A. Another fellow from Dayton, I can't 10 think of his first -- oh, Doug Hess, H E S S. 11 Q. Of the cases that you currently 12 have, are any of them plaintiff's cases? 13 A. The one with Mr. Hess. 14 Q. Although Mr. Hess's case is still 15 current? 16 A. Correct. 17 Q. The other -- I'm sorry, did you say 18 you had about 10 open cases? 19 A. Oh, probably six, maybe. 20 Q. Okay. So the other roughly five 21 cases would be defense cases? 22 A. I've got another -- it would be five 23 and two, yeah. 24 Q. Two plaintiffs cases and five SPANGLER REPORTING SERVICES, INC. 0051 1 defense cases? 2 A. That would be about right. 3 Q. In a patient that's 55-years old, 4 that is African American, that has abnormal 5 uterine bleeding, that is diabetic, what do you -- 6 what signs and symptoms do you look for in your 7 patients to suspect some form of uterine cancer? 8 MR. RIEMENSCHNEIDER: Just note an 9 objection to the vagueness and the multiple types 10 of uterine cancers. 11 Q. Go ahead, Doctor. 12 A. Well, I think you have to, in any 13 age group, if they have abnormal bleeding, you 14 have to at least have that on the radar as a 15 possibility of, in particular, endometrial cancer. 16 Q. The fact that uterine sarcomas -- 17 strike that. 18 Uterine sarcomas are rare, aren't 19 they? 20 A. Exceedingly rare. 21 Q. The fact that they're exceedingly 22 rare, that isn't an excuse in the event that the 23 signs and symptoms should have led to a diagnosis 24 if certain tests had been ordered, can we agree SPANGLER REPORTING SERVICES, INC. 0052 1 upon that? 2 A. No. 3 Q. I'm sorry, Doctor? 4 A. No. 5 Q. Your answer was no? 6 A. Yes, that's my answer. 7 Q. Okay. I'm sorry, I didn't hear the 8 answer. The fact that something is rare, is that 9 an excuse for missing a diagnosis? 10 A. No. 11 Q. Would you agree that in gynecology, 12 as in many branches of medicine, you have to have 13 a differential? 14 A. Yes. 15 Q. And often times certain things that 16 are higher on the differential are more common 17 causes for a patient's symptoms? 18 A. Yes. 19 Q. And can we agree that in gynecology, 20 when you're acting reasonably and prudent, that 21 there are times where the item, which is less 22 common on the differential ultimately proves to be 23 the diagnosis? 24 A. Sure, that could happen. SPANGLER REPORTING SERVICES, INC. 0053 1 Q. Often times in gynecology you can 2 make what's known as an incidental diagnosis while 3 you're working up a patient for another suspected 4 condition, correct? 5 A. You'll have to repeat that question. 6 Q. Sure. When you're treating a 7 patient as a gynecologist and working them up for 8 potential causes for their GYN issue, can we agree 9 that it's not infrequent that you come across an 10 incidental finding that wasn't high up on your 11 differential when you first started working up the 12 patient? 13 A. If you've done a good differential 14 it should be very, very infrequent. 15 Q. I'm sorry, sir? 16 A. If you'd done a very good 17 differential diagnosis it should be very 18 infrequent that that happens. 19 Q. Okay. In the event that you do find 20 something that leads to an uncommon diagnosis, 21 would you agree that there's a responsibility on 22 the part of the gynecologist to recognize the 23 condition, even though it's rare, and refer that 24 patient to the appropriate specialist? SPANGLER REPORTING SERVICES, INC. 0054 1 A. No. Your questions are quite 2 confusing and presumptive, I'm not sure where 3 you're trying to go. If you're trying to say 4 because she had a sarcoma that we should have made 5 that our differential diagnosis, I disagree with 6 that. 7 Q. If certain tests had been done, 8 certain interventions had been done and sarcoma 9 had been diagnosed earlier, would you agree that, 10 even though it's a rare condition, that wouldn't 11 excuse hypothetically the GYN from referring the 12 patient to the appropriate specialist? 13 MR. RIEMENSCHNEIDER: Objection. 14 A. I have never in 30 years of medicine 15 ever made a diagnosis of uterine sarcoma prior to 16 surgery ever. 17 Q. Okay. Is hysterectomy the way that 18 the diagnosis of uterine sarcoma is made? 19 A. Yes. 20 Q. So, again, hypothetically, if 21 hysterectomy is done, an uterine sarcoma is found, 22 that is frequently, at least based upon your 23 knowledge, training, experience, an uncommon 24 diagnosis? SPANGLER REPORTING SERVICES, INC. 0055 1 A. Yes. 2 Q. But even though it's uncommon, that 3 an hysterectomy is done and uterine sarcoma is 4 diagnosed, even though you were working the 5 patient up for some other GYN illness or disease, 6 is there a duty or a responsibility to refer that 7 patient for specialized care and treatment? 8 A. Yes. 9 Q. Before we go back to the opinions 10 that you have in this case, I want to just ask you 11 a couple more questions relative to your 12 medical/legal work. First, your report dated in 13 August of '08, when were you first contacted on 14 this case? 15 A. Probably in the spring of last year. 16 Q. Spring of '08, sir? 17 A. That would be a pretty good guess, 18 yes. 19 Q. How did Mr. Riemenschneider obtain 20 your name? 21 A. I had cases with Dirk before when he 22 was down here in Cincinnati. 23 Q. How many? 24 A. Maybe two. Years ago. SPANGLER REPORTING SERVICES, INC. 0056 1 Q. Is it your testimony that this would 2 be the third case that you served as an expert? 3 A. Probably. 4 Q. Have you ever testified up here in 5 Northeastern Ohio? 6 A. Not to my knowledge. 7 Q. And when I say "Northeast Ohio," I'm 8 talking about Cleveland, Akron. 9 A. Right. 10 Q. Have you ever been involved in a 11 case as an expert on either side where there was 12 an issue about the timeliness or lack thereof 13 concerning uterine cancer? 14 A. Yes, I have. 15 Q. How many, sir? 16 A. Just one. 17 Q. Was that one for Mr. Gibson? 18 A. No. That was a defense case. 19 Q. When was that, sir? 20 A. 2000. 21 Q. I'm sorry? 22 A. The year 2000. 23 Q. That was down in Dayton? 24 A. That was in Dayton, yes. SPANGLER REPORTING SERVICES, INC. 0057 1 Q. What was the nature of the cancer? 2 A. Sarcoma. 3 Q. Uterine sarcoma? 4 A. Yes. 5 Q. In that case did you -- was your 6 testimony limited to standard of care? 7 A. Yes. 8 Q. You didn't provide any causation? 9 A. Correct. 10 Q. Same as you're doing in this case? 11 A. Yes. 12 Q. Do you recall the type of uterine 13 sarcoma? 14 A. I don't. 15 Q. What was the name of that case? 16 A. Hmm, I have no idea. It was 17 Foreman, Freund & Freeze. The attorney was Susan 18 Blazic Miller. 19 Q. Okay. Did the patient die in that 20 case? 21 A. Not at the time of trial. 22 Q. I take it from your answer that you 23 learned subsequent to the trial that the patient 24 died? SPANGLER REPORTING SERVICES, INC. 0058 1 A. I don't know. 2 Q. Other than the article that you're 3 going to make a copy of for me that I think we 4 agreed would be Exhibit 1, is there any other 5 literature that you intend to rely on to reference 6 or support any of the opinions that you hold in 7 this case? 8 A. No. 9 Q. Doctor, I know that you are -- and I 10 don't mean this in a derogatory sense, but you're 11 an advocate of alternatives to hysterectomy where 12 it's safe and efficacious? 13 A. Yes. 14 Q. We can agree, however, that if there 15 was reason to suspect that Lillian had uterine 16 cancer, not limited to sarcoma, but uterine 17 cancer, would there have been any other treatment 18 that would have been efficacious for her short of 19 an hysterectomy? 20 MR. RIEMENSCHNEIDER: Objection. 21 Go ahead. 22 A. We're saying with a diagnosis of 23 some type of uterine cancer? 24 Q. Yes, sir. SPANGLER REPORTING SERVICES, INC. 0059 1 A. Then there is no other alternative 2 beside hysterectomy. 3 Q. And other than that which you've 4 learned from Dr. Young by looking at his 5 deposition, if an hysterectomy hypothetically had 6 been done in May of 2005, do you know first 7 whether more likely than not, or do you have an 8 opinion whether more likely than not her uterine 9 sarcoma would have been diagnosed? 10 A. If an hysterectomy was done in you 11 said June of '05? 12 Q. Well, yes, May or June, but -- 13 A. Okay. Yeah, I think it would have 14 been diagnosed, yes. 15 Q. Okay. As far as the staging of the 16 uterine sarcoma, putting aside the information 17 that you have derived from one of the experts in 18 this case, do you know, based upon your knowledge, 19 training, experience, as to what the stage of her 20 uterine sarcoma would have been at that time? 21 A. I have no idea. 22 Q. You're not able to say, are you, 23 that the uterine sarcoma in May or June, if, 24 hypothetically, the patient would have had an SPANGLER REPORTING SERVICES, INC. 0060 1 hysterectomy, whether or not it would have been 2 confined to the uterine corpus or right outside of 3 the uterus? 4 A. My opinion is it would have already 5 been spread. But there's no way -- you're giving 6 a hypothetical, and that's all I can do, too. 7 Q. There's nothing clinically that 8 you're aware of in May or June that would have 9 shown any metastatic disease, either on the 10 ultrasound or on any blood work, or even the 11 endometrial biopsy, that would have been 12 consistent with spread outside the uterus, 13 correct? 14 MR. RIEMENSCHNEIDER: Objection. 15 Go ahead. 16 A. None of those tests are going to 17 predict metastasis. 18 Q. And we have nothing prior to the 19 time that the hysterectomy is done to know the 20 degree of metastatic disease, correct? 21 MR. RIEMENSCHNEIDER: Objection. 22 Go ahead. 23 A. Obviously not. 24 Q. Doctor, in your practice, when a SPANGLER REPORTING SERVICES, INC. 0061 1 patient presents that's in their mid-50s that has 2 abnormal uterine bleeding, and you consider the 3 patient to be perimenopausal, is it your 4 responsibility to rule out malignancies? 5 A. Yes. 6 Q. And can we agree that abnormal 7 uterine bleeding can only be treated as a benign 8 condition once a malignancy has been ruled out? 9 A. Yes. 10 Q. I want to talk about Dr. Verghese, 11 one of the doctors that was involved in this case. 12 Do you recall that she saw Lillian in May and June 13 of 2005? 14 A. Yes. 15 MR. MISHKIND: V E R G H E S E, E S 16 E, S as in Sam. I think it's also reflected -- 17 it's improperly reflected in the Doctor's letter, 18 but I think Dirk will confirm that I spelled it 19 correctly, maybe not, I don't know. 20 BY MR. MISHKIND: 21 In any event, Doctor, you're aware 22 that Dr. Verghese saw Lillian in May and June? 23 A. Yes. 24 Q. You have handy the record for the SPANGLER REPORTING SERVICES, INC. 0062 1 May 4, 2005 visit? 2 A. No, I don't. I just have my notes. 3 MR. RIEMENSCHNEIDER: The record's 4 here, if you want. 5 MR. MISHKIND: Yeah. What I want 6 him to do is just to confirm -- I don't want to 7 misstate anything in the record -- that when she 8 was seen, when Lillian was seen on May 4, 2005, 9 that Dr. Verghese made a note that she had been 10 complaining of daily bleeding, light and heavy, 11 for four months, and that her last period was 12 April of '04 and previous to that March of '04. 13 A. Ah, bah, bah. I see last menstrual 14 period 12/04, correct. 15 Q. No. I'm looking at her actual notes 16 "Complaining of daily bleeding, light and heavy"? 17 A. I've got a different one here. 18 Q. It would be May 4, '05? 19 MR. RIEMENSCHNEIDER: That's the 20 nurse's note. 21 A. Okay. I've got you. Here we are. 22 Q. Okay. 23 A. Perimenopausal bleeding, yes. 24 Q. She's got a number of diagnoses, SPANGLER REPORTING SERVICES, INC. 0063 1 perimenopausal bleeding? 2 A. Yeah. 3 Q. She's got a note that says 4 "endometrial biopsy." What's that ECC? 5 A. Yeah. Endocervical curettage. 6 Q. May 4, 2005. And that next is 7 fibrous uterus? 8 A. Fibroid uterus, yeah. 9 Q. Fibroid uterus, and then gravital, 10 peri 1? 11 A. Yes. 12 Q. And then irregular bleeding? 13 A. Okay. 14 Q. Those are the diagnoses, correct? 15 A. Yes. 16 Q. And then in her history do you see 17 where she marked down -- do you recall whether 18 there was a history that the doctor had obtained 19 from the patient? 20 A. I would assume so. 21 Q. Okay. And was that not, in fact, 22 confirmed, based upon her deposition testimony 23 that this was a history that she obtained from the 24 patient? SPANGLER REPORTING SERVICES, INC. 0064 1 A. I believe so. 2 Q. Okay. And if I'm reading it 3 correctly, and certainly as you're looking at 4 this, can we agree that it says that this is a 5 55-year old, then skipping to the next line it 6 says complaining of daily bleeding -- 7 THE COURT REPORTER: I'm sorry 8 Counselor -- Counselor? 9 MR. MISHKIND: Yes, ma'am? 10 THE COURT REPORTER: It says that 11 this is a 55-year old -- 12 Q. Then I -- it talks about the 13 gravital 1, peri 1, and I went to the next line. 14 You're with me, Doctor? 15 A. Yeah, I'm here. 16 Q. It says "Complaining of daily 17 bleeding, light and heavy"? 18 A. Yes. 19 Q. For four months? 20 A. Yes. 21 Q. Since December 2004? 22 A. Yes. 23 Q. And then it says her last menstrual 24 period was April 2004? SPANGLER REPORTING SERVICES, INC. 0065 1 A. Yes. 2 Q. And then previous to that March of 3 2004? 4 A. Okay. 5 Q. Now, as of May 2005, was there any 6 evidence that what we learned ultimately to be 7 uterine sarcoma, any evidence clinically or 8 diagnostically that the uterine sarcoma had spread 9 outside the uterine walls? 10 MR. RIEMENSCHNEIDER: Objection. 11 Go ahead. 12 A. I have no evidence. 13 Q. Now, the fact that Lillian did not 14 complain of any pain in May or June, does that 15 mean, in your opinion, that she did not have 16 uterine sarcoma? 17 MR. RIEMENSCHNEIDER: Objection. 18 A. No. It just means that she didn't 19 have any pain. 20 Q. Well, is it necessary to make a 21 diagnosis or to suspect a diagnosis of uterine 22 sarcoma that one has to have pain? 23 A. Well, it certainly would put it a 24 little bit more on the radar, but I don't think SPANGLER REPORTING SERVICES, INC. 0066 1 you have to have -- 2 If we're looking at fibroids, the 3 question is what kind of symptoms is this patient 4 having. Nobody's saying that this patient has 5 sarcoma. The diagnosis here is uterine fibroids. 6 And the fact that she doesn't have pain and the 7 fact that her blood levels is hematocrit 42, which 8 means she's not bleeding that heavily, I'd say 9 it's pretty close to asymptomatic fibroids. 10 Q. In order to have an index of concern 11 that the patient has uterine sarcoma, do you need 12 to have within the symptom complex a complaint of 13 pain? 14 A. That usually accompanies it, yes. 15 Q. Without that, can one confidently 16 rule out uterine sarcoma? 17 A. No. 18 Q. Okay. Now, in your report you 19 indicate that she had -- this is on the second 20 page, sir? 21 A. Yes. 22 Q. Last paragraph. She had two 23 ultrasounds six months apart that were essentially 24 unchanged? SPANGLER REPORTING SERVICES, INC. 0067 1 A. Yes. 2 Q. Now, I have copies of the ultrasound 3 interpretation which I guess you had also when you 4 prepared your report? 5 A. Yes. 6 Q. And can we agree, first of all, that 7 both reports, in November and then ultimately in 8 May, both reports are noted on the actual official 9 report to be abnormal? 10 A. They're all stating "uterine 11 fibroids," yes. 12 Q. They say "abnormal" on the report, 13 correct? 14 A. I don't have the report in front of 15 me. 16 Q. You accept that as a fact, though? 17 A. If you say that that's what's there, 18 I'll believe you. 19 Q. In terms of the measurement, the 20 fibroid, the largest fibroid in November was 5.4 21 centimeters? 22 A. Yes. 23 Q. And then the largest fibroid in May 24 was 10.7 centimeters? SPANGLER REPORTING SERVICES, INC. 0068 1 A. Yes. 2 Q. Now, that's nearly doubling in size, 3 is it not? 4 MR. RIEMENSCHNEIDER: Objection. 5 A. Well, that's doubling of one 6 fibroid, but it's certainly not doubling the 7 entire uterine mass at all. 8 Q. No, I know. But it is a significant 9 change in terms of what is viewed to be on 10 ultrasound a fibroid, correct? 11 A. I would not consider that 12 significant, no. 13 Q. In six-months period a doubling of a 14 fibroid tumor in a patient who's 55, 15 perimenopausal with abnormal uterine bleeding, a 16 5.4 centimeter to a 10.7 centimeter over a 6-month 17 period, you don't view that as significant? 18 A. No, I don't. 19 Q. Can you provide me with any 20 literature at all that would support the 21 contention that that growth over that period of 22 time is not significant? 23 A. It is most likely a benign fibroid. 24 Q. How does one know that it is a SPANGLER REPORTING SERVICES, INC. 0069 1 benign fibroid? 2 A. Thirty years medical experience. 3 Q. Can you cite me, other than your 30 4 years of medical experience and 20 years serving 5 as an expert, can you cite me to any peer reviewed 6 evidence based literature that would suggest in a 7 55-year-old patient with abnormal uterine bleeding 8 that has an increase from November to May of a 9 fibroid from 5.4 to 10.7 that one can conclude 10 without further intervention that that is a 11 fibroid tumor and not a malignancy? 12 MR. RIEMENSCHNEIDER: Objection. 13 A. You're going to have to give that 14 question again, Howard. 15 Q. Can you cite me to any peer review 16 literature, anything that your colleagues have 17 written that would support the contention that one 18 can conclude that this is a benign fibroid tumor 19 and not a potential malignancy that needs to be 20 worked up? 21 A. Actually, the article that I have 22 from Dr. Parker in Los Angeles, that article I 23 think will explain it to you what is considered to 24 be rapid growth. It has no consideration SPANGLER REPORTING SERVICES, INC. 0070 1 whatsoever in a perimenopausal woman, and you'll 2 be getting that article. 3 Q. Okay. Now, your ultra -- your 4 statement in your report that the two ultrasounds 5 were essentially unchanged, that's not true, is 6 it? 7 A. Yes, it is true. 8 Q. Well, Doctor, not only did the 9 fibroid go from 5.4 to 10.7, but the measurement 10 of the uterus went from 12.7 by 9.5 by 10.2 in 11 November to 14.8 by 10.9 by 9.7 in May, correct? 12 A. There's been an enlargement of the 13 uterus, but it's not significant, not in a 14 perimenopausal woman. 15 Q. And are you suggesting that with 16 negative endometrial biopsy, that you, as a 17 reasonable and prudent gynecologist, can rule out 18 a malignancy that requires surgical intervention? 19 A. I believe it was your own expert 20 witness that said that the endometrial biopsy 21 picked up two-thirds of malignancies. 22 Q. Well, let me ask you: 23 Regardless of whether that's an 24 accurate or inaccurate statement with a negative SPANGLER REPORTING SERVICES, INC. 0071 1 endometrial biopsy with the growth, whether you 2 describe it as unchanged or not, we have an 3 increase in size of a fibroid tumor; the 4 dimensions of the uterus, I've described them 5 accurately, have I not? 6 A. Pretty good. 7 Q. And is it your testimony that 8 hysterectomy was not indicated as of May or June 9 of 2005? 10 A. Absolutely not indicated. 11 Q. Are you suggesting that you would 12 have treated this patient with the initiation of 13 hormone therapy like what Dr. Verghese gave? 14 A. That's progesterone Provera therapy 15 and, yes, I would have done exactly the same 16 thing. 17 Q. Now, I want to understand completely 18 why hysterectomy wouldn't have been indicated, 19 taking into account the entire clinical history 20 that Dr. Verghese would have had as of May and 21 June of 2005, including her age, all of her risk 22 factors, everything that a reasonable and prudent 23 OB-GYN or I'm sorry, a GYN should consider, why 24 was it not the standard of care to have done an SPANGLER REPORTING SERVICES, INC. 0072 1 hysterectomy at that time? 2 A. I think we've gone over this, 3 Howard. 4 Q. Well, I just want to make sure. 5 Now as of -- and I'm not trying to 6 repeat things, Doctor, so please forgive me. I 7 just want to understand why an hysterectomy at 8 that point, which now having reviewed the 9 ultrasound which you describe as unchanged -- let 10 me come at it a different way. I'll dive in 11 differently. 12 Are you under oath holding the 13 position that the term "unchanged" is an accurate 14 description? 15 A. I would say relatively unchanged. 16 And as I say, I think we've agreed to the point 17 that they did indeed get larger, but the question 18 is: Is it significant given this clinical 19 setting? 20 Now, I'll go through it again for 21 you. We have asymptomatic fibroids, okay? This 22 patient is -- there's two reasons that we want to 23 do an hysterectomy on a patient, because she's had 24 uncontrollable bleeding or she has pain. Anything SPANGLER REPORTING SERVICES, INC. 0073 1 short of that is an unnecessary hysterectomy. 2 Q. And you believe that this article 3 that you have will support that contention? 4 A. I believe so. 5 Q. If she was not perimenopausal, would 6 that change your opinion? 7 A. As long as I'd ruled out endometrial 8 cancer, no, it wouldn't have changed my opinion. 9 Q. Even in a menopausal woman where 10 you've done an endometrial biopsy with all of her 11 clinical findings as well as the diagnostic 12 findings, you believe it still would be reasonable 13 and prudent not to do an hysterectomy? 14 A. It's certainly more concerning in an 15 older woman who's been menopausal, but again, 16 she's totally asymptomatic. And particularly in 17 this case I would be more concerned if that 18 menopausal patient, average age being 63 when 19 sarcomas are usually diagnosed, if she indeed had 20 pain, I would be very significantly -- I think 21 then she would need an hysterectomy, yes. She's 22 still asymptomatic, whether she's menopausal or 23 not. 24 Q. Symptomatic being having pain? SPANGLER REPORTING SERVICES, INC. 0074 1 A. Pain. 2 Q. Any other symptoms that you would 3 have had to have seen to have tipped your index of 4 suspicion? 5 A. No. 6 Q. So without the pain, every else that 7 she had, growth in the fibroid, whatever we want 8 to debate about the measurements, her abnormal 9 uterine bleeding, it's your opinion that a 10 reasonable and prudent GYN surgeon as of May and 11 June of 2005 didn't need to perform an 12 hysterectomy on this patient to further evaluate 13 the risk of a cancer and/or a sarcoma? 14 A. That's my opinion. 15 Q. And, Doctor, in essence, is that the 16 sum of your opinions that you intend to provide at 17 the trial of this case? 18 A. Right now, yes, um-hmm. 19 Q. When you say "right now," do you 20 plan on coming up with any additional opinions? 21 A. I don't know. It depends on further 22 depositions. 23 Q. Well, certainly to the extent that 24 you were to come up with any additional opinions SPANGLER REPORTING SERVICES, INC. 0075 1 other than those which we talked about in the 2 deposition: A, I would object to that; and B, I 3 would certainly want to know about them before you 4 took the stand. 5 A. Absolutely. 6 MR. RIEMENSCHNEIDER: Well, just so 7 we're clear -- I mean, his report indicates he 8 feels that the Ohio Permanente met the standard of 9 care so -- 10 MR. MISHKIND: Right. That's what 11 I asked him before, in terms of whether there was 12 any breach in the standard of care. 13 BY MR. MISHKIND: 14 Q. And you feel that all of the care 15 from November through the time of the diagnosis 16 was exactly what you would have done and, in fact, 17 complied with the standard of care? 18 A. Yes. 19 Q. And standard of care as far as the 20 scheduling of follow-up visits, assuming she was 21 told and didn't schedule a follow-up visit, you 22 don't believe that that would have altered the 23 outcome in this case? 24 A. Not a bit. SPANGLER REPORTING SERVICES, INC. 0076 1 Q. And if, in fact, she wasn't told to 2 schedule a visit, and wasn't advised of the 3 results of the ultrasound, you don't believe that 4 that constitutes substandard care of a patient? 5 A. Well, you put a lot of questions in 6 there. I'm going to just say no. 7 Q. Okay. I'm not trying to make it 8 more complicated than necessary. 9 A. It's kind of like run-on sentences, 10 Howard. 11 Q. I know. 12 MR. RIEMENSCHNEIDER: And also it's 13 been asked and answered pretty thoroughly at the 14 beginning of the deposition. 15 MR. MISHKIND: You expect me to 16 remember how I talked about it. 17 MR. RIEMENSCHNEIDER: I do, because 18 I know how you do it, you're brilliant. 19 MR. MISHKIND: Yeah. 20 Let's do this, let's go off the 21 record for about two minutes. I just want to 22 review my notes. I think we are coming to the 23 finish line, Doctor, but rather than wasting the 24 video and the court reporter's time, if we could SPANGLER REPORTING SERVICES, INC. 0077 1 take a moment's break. 2 THE VIDEOGRAPHER: We're going off 3 the record. One second, please. We're off. 4 (Brief recess.) 5 THE VIDEOGRAPHER: This is a 6 continuation of tape number one. The time now is 7 3:48. You're back on the record. 8 BY MR. MISHKIND: 9 Q. Doctor, we are heading towards the 10 home stretch. I have about 8 or 9 questions and 11 we'll be done. 12 First, I think while we were off the 13 record the court reporter has marked the exhibits 14 which would include your notes relative to the 15 review. What I wanted you to do is to tell me 16 either in a summary fashion or by reading from 17 your notes what you've marked down that I presume 18 is in contrast to Dr. McLellan, I think you said 19 part of your notes had to do with your deposition? 20 A. Yes. 21 Q. If you could either read that or 22 look at the notes and summarize what you're trying 23 to convey? 24 A. If you've got a fax machine, I can SPANGLER REPORTING SERVICES, INC. 0078 1 fax them right up to you. 2 Q. You know what, by the time we go off 3 the record -- why don't you just tell me what 4 you've got there or summarize what it is that you 5 felt that -- I presume you disagree with Dr. 6 McLellan? 7 A. Yes. 8 Q. And is that what you've got noted 9 there? 10 A. Well, I just thought there were some 11 very interesting points in his deposition. 12 Q. Okay. Tell me what those are, sir. 13 A. Basically that -- that he agrees 14 there was bleeding and there was no pain. The 15 endo biopsy was inactive endometrium, the 16 ultrasounds we talked about. Dr. McLellan 17 admitted that tumor was very aggressive and admits 18 50 percent mortality even at stage 1. Peri- or 19 post-menopausal bleeding, it says, "rapidly 20 enlarged uterus." He gives the opinion of 30 to 21 50 percent enlargement over six months. 22 I would like to see that reference 23 myself, because I've never been able to find a 24 reference as to what somebody thinks is rapidly SPANGLER REPORTING SERVICES, INC. 0079 1 growing, so I would be glad to see that reference. 2 Can't -- Well, I guess I can't 3 disagree with Dr. -- oh -- Mishner was the surgeon 4 that eventually did the surgery, and he agreed -- 5 and again this is December before the surgery, the 6 GYN oncologist in Cleveland thought that there was 7 a "very low chance of sarcoma, even at this late 8 date," which he admits, too, was significant. 9 He was critical of Dr. Green who 10 gave the DepoLuprin, and that certainly didn't 11 change anything. 12 Q. Would you have given DepoLuprin? 13 A. I don't think we needed DepoLuprin 14 at that time. I think they were probably just 15 trying to see, number one, if the fibroids would 16 go away or give her some relief before she had the 17 surgery. I don't disagree. 18 THE COURT REPORTER: I'm sorry, 19 counsel, I didn't hear your question. 20 Q. I'm sorry. I said, but you wouldn't 21 have done what Dr. Green did, would you? 22 A. At that stage it meant -- would I 23 have given DepoLuprin, probably not, but did it 24 change anything? The answer is no. SPANGLER REPORTING SERVICES, INC. 0080 1 Q. Continue, please. 2 A. Anyway, he states that a Pipelle 3 will pick up sarcoma two-thirds of the time which 4 I thought was very interesting. Because that's 5 much higher than I would expect. And the fact -- 6 in addition to the fact that we have a normal 7 endometrial biopsis. 8 So if two-thirds of the time you 9 could pick up a sarcoma, then if there was a 10 sarcoma or if I was supposed to be concerned about 11 it, then I would have been concerned about it 12 then. So I mean that just furthers my argument 13 that there was really no indication for that 14 hysterectomy. 15 Q. Anything else of substance from Dr. 16 McLellan? 17 A. That's pretty much it. 18 Q. Okay. Doctor, what percentage of 19 your income is generated on a yearly basis from 20 medical legal work? 21 A. Probably about five percent, five to 22 ten at the most, closer to five. 23 Q. The uterine mass that was growing 24 from 5.4 to 10.7 from November to May, what -- SPANGLER REPORTING SERVICES, INC. 0081 1 what do you believe was causing that mass to grow? 2 A. Fibroids. 3 Q. In retrospect, knowing what the 4 ultimate diagnosis was, what do you believe was 5 causing it to grow? 6 MR. RIEMENSCHNEIDER: Objection. 7 A. Retrospectively, it was probably the 8 sarcoma, yes. 9 Q. Do fibroids typically grow or shrink 10 as a woman enters menopause? 11 A. You're skirting on the question 12 here. 13 Q. I'm sorry, sir? 14 A. If you're talking about menopause, 15 all right, which this woman was not menopausal, 16 then clearly they shouldn't be enlarging. In 17 perimenopausal, they enlarge all the time. 18 Q. Now, if a 55-year-old African 19 American woman such as Lillian Dailey came to your 20 office complaining of continuous vaginal bleeding 21 after not having a period for six months, you note 22 she's obese, you note she's diabetic, you also 23 note that she has had what the ultrastenographer 24 had indicated was abnormal ultrasound, SPANGLER REPORTING SERVICES, INC. 0082 1 transvaginal ultrasound within the past six 2 months, and an endometrium that measured .9 3 centimeters, and she had a large fibroid that had 4 grown from November to May, what would have been 5 within your differential at that time 6 prospectively? 7 A. Give me the question again, Howard. 8 Q. Sure. A woman comes into your 9 office, 55-years old, African American, medical 10 history diabetes -- 11 A. Oh, God. 12 Q. Obesity, irregular uterine bleeding, 13 no period in the last six months, an abnormal 14 ultrasound, an abnormal ultrasound by 15 interpretation by the ultrastenographer, a large 16 fibroid that has increased in size from 5.4 to 17 10.7, an endometrium that measures .9 centimeters, 18 prospectively looking at that case history, what 19 would have been within your differential 20 diagnosis? 21 MR. RIEMENSCHNEIDER: Objection. 22 A. Clearly endometrial cancer would 23 have been in that diagnosis, and that's the reason 24 that I would have done the biopsy just like Dr. SPANGLER REPORTING SERVICES, INC. 0083 1 Verghese did. And the biopsy came back negative, 2 patient had a hematocrit of 42, she didn't have 3 any pain. I wouldn't have done anything 4 differently. 5 Q. Would your differential diagnosis at 6 that time have been limited solely to uterine 7 cancer? 8 A. And fibroids. 9 Q. And fibroids. You would not have 10 had within your differential uterine sarcoma? 11 A. Never have. 12 Q. We can agree that an endometrial 13 biopsy that is negative, at least in your 14 experience, cannot rule out uterine sarcoma? 15 A. Correct. 16 Q. If uterine sarcoma was in the 17 differential hypothetically, and I recognize 18 that's what you've just told me, but if it was 19 within the differential, even though not high in 20 the differential, would the benefit of doing an 21 hysterectomy in this woman at her age have 22 outweighed the risk of an hysterectomy in your 23 opinion? 24 A. I don't believe so. She was high SPANGLER REPORTING SERVICES, INC. 0084 1 risk for any kind of surgery. 2 Q. Why, sir? 3 A. She was high risk for any kind of 4 surgery. 5 Q. No, I'm sorry, I was asking you why 6 would you say that the risk, if uterine sarcoma 7 was in the differential, why the risk of an 8 hysterectomy, what is it indigenous or relative to 9 her that would have made the risk exceed the 10 benefit? 11 A. She's obese, she's diabetic, she's 12 hypertensive, it would be risky surgery. Her 13 morbidity on a surgery like this would probably 14 approach 25 percent. 15 Q. Meaning 75 percent of the time she 16 would have made it through the surgery? 17 A. Yes. 18 Q. Okay. Just looking for one other 19 thing, and I think if I find it that will be my 20 last question or second last question. I don't 21 want Dirk to hold me to that. Well, I can't find 22 it, so I'm not going to take any more of your 23 time. 24 I just want to make sure that I've SPANGLER REPORTING SERVICES, INC. 0085 1 given you an opportunity, a fair opportunity, even 2 though we're not face-to-face, to explain the 3 opinions that you hold and the bases for those 4 opinions. 5 A. You've been very fair. 6 Q. And in terms of the standard of care 7 and the bases for why you believe the standard of 8 care was met, have I given you a full opportunity 9 to explain that? 10 A. I believe you have. 11 Q. And I won't be surprised by you 12 giving a causation opinion or approximate cause 13 opinions at the trial of this case? 14 A. I will not do that. 15 MR. RIEMENSCHNEIDER: Unless you 16 ask him I guess, Howard, since you asked him quite 17 a bit after he told you he wasn't opining on it. 18 MR. MISHKIND: Well, that's what 19 the discovery deposition is all about, isn't it? 20 MR. RIEMENSCHNEIDER: Yeah, I guess 21 so. 22 MR. MISHKIND: All right. Doctor, 23 I appreciate your time and I appreciate you 24 obliging me in this manner to do the deposition. SPANGLER REPORTING SERVICES, INC. 0086 1 With that I have no further questions. 2 THE WITNESS: Not a problem. Thank 3 you. 4 MR. RIEMENSCHNEIDER: Have a good 5 night, Howard. 6 MR. MISHKIND: You, too. And 7 obviously the Doctor will read the depo and we'll 8 go from there. 9 THE WITNESS: She -- I think 10 someone has something to ask you. Hello. 11 MR. RIEMENSCHNEIDER: Marlene. 12 THE VIDEOGRAPHER: You have the 13 right to review the video, but you can waive that, 14 too. 15 MR. RIEMENSCHNEIDER: He'll waive 16 reviewing the video, but we'll reserve the right 17 to review the deposition. 18 THE VIDEOGRAPHER: Okay. This is 19 the end of the deposition. This is the end of 20 tape one of one. The time now is 4:00. 21 One second, we're going off the 22 record. We're off. 23 (Plaintiff's Exhibits 1 and 2 were marked for 24 identification.) SPANGLER REPORTING SERVICES, INC. 0087 1 2 3 WILLIAM MALCOLM JAMIESON, III, M.D. 4 - - - 5 DEPOSITION CONCLUDED AT 3:58 P.M. 6 - - - 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 SPANGLER REPORTING SERVICES, INC. 0088 1 C E R T I F I C A T E 2 STATE OF OHIO : 3 : SS 4 COUNTY OF HAMILTON : 5 I, PAMELA SUE SPANGLER, RPR, the 6 undersigned, a duly qualified and commissioned 7 notary public within and for the State of Ohio, do 8 hereby certify that before the giving of his 9 aforesaid deposition, the said WILLIAM MALCOLM 10 JAMIESON, III, M.D. was by me first duly sworn to 11 tell the truth, the whole truth and nothing but 12 the truth; that the foregoing is the deposition 13 given at said time and place by the said WILLIAM 14 MALCOLM JAMIESON, III, M.D.; that said deposition 15 was taken in all respects pursuant to Notice to 16 Take Deposition, duly issued and served, and 17 agreement; that said deposition was taken by me in 18 stenotypy and transcribed by computer-aided 19 transcription under my supervision; that the 20 transcribed deposition is to be submitted to the 21 witness for his examination and signature; that I 22 am neither a relative of nor attorney for any of 23 the parties to this cause, nor relative of nor 24 employee for any of their counsel, and have no SPANGLER REPORTING SERVICES, INC. 0089 1 interest whatever in the result of the action. 2 IN WITNESS WHEREOF, I hereunto set my 3 hand and official seal of office at Cincinnati, 4 Ohio, this day of , 2009. 5 6 7 MY COMMISSION EXPIRES: PAMELA SUE SPANGLER, RPR 8 APRIL 28, 2012. NOTARY PUBLIC-STATE OF OHIO 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 SPANGLER REPORTING SERVICES, INC.